[Sitagliptin (type 2 diabetes mellitus) - Benefit assessment according to § 35a Social Code Book V (expiry of the decision)]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003470
German
Original Title:
Sitagliptin (Diabetes mellitus Typ 2)
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a18-65.html
Year Published:
2018
URL for published report:
https://www.iqwig.de/download/A18-65_Sitagliptin_Nutzenbewertung-35a-SGB-V_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Diabetes Mellitus, Type 2
- Sitagliptin Phosphate
- Hypoglycemic Agents
Keywords
- Sitagliptin
- Diabetes Mellitus - Type 2
- Benefit Assessment
- NCT00094770
- NCT00701090
- NCT00838903
- NCT00790205
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.